Home›Stocks›EPRX

EPRX — structural market context

Eupraxia Pharmaceuticals Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 14. Each line shows the earlier value, the later value and their dates.

Price

Close $6.59 (Oct 14) vs $6.68 (Oct 13): −1.35%.

Volume

0.28× its 20-session average (995K) on Oct 14.

Includes pre- and post-market trading.

Short interest

Short interest 6.8M shares (settlement Sep 30) vs 7.6M (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 1–Sep 14, published Sep 30): 3 days with fails, largest 20K shares on Sep 3.

Previous file (settlements Aug 17–Aug 31, published Sep 16): 1 day with fails, largest 1K shares on Aug 20.

No new publication in this window.

Analyst rating actions

None recorded in this window.

EPRX short interest & days to cover

SHARES SHORT
6.8M
% OF FLOAT
—
DAYS TO COVER
11.1
CHANGE VS PRIOR
-10.3%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (15d ago)

EPRX fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-14 · 31d2K$8.42
2026-09-09 · 36d1K$8.25
2026-09-03 · 42d20K$7.45

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

EPRX analyst ratings

FirmActionRatingPublished
Cantor FitzgeraldholdOverweight2026-10-08
H.C. WainwrightholdBuy2026-10-01
H.C. Wainwrightprice_target—2026-10-01
WedbushinitialiseOutperform2026-09-24
Wedbushprice_target—2026-09-24

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What do analysts say about EPRX?
The most recent action: Cantor Fitzgerald hold to Overweight on 2026-10-08. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell EPRX?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with E

EENEF · RS GROUP PLCEERGF · ENERGEAN OIL AND GAS PLC Ord GEONGY · E.ON SE Sponsored ADR (GermanyETN · Eaton Corporation, plc OrdinarEDIT · Editas Medicine, Inc. Common SELMUF · Elisa Corporation Ordinary ShaAll E →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.